Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2
This article discusses hereditary MTC
in the setting of MEN2 and the treatment options available for it. The first
line treatment for this disease is typically a total thyroidectomy and tyrosine
kinase inhibitors. Two tyrosine kinase inhibitors, vandetanib and cabozantinib,
have been approved for treatment of advanced MTC, but options beyond those are
limited. However, several promising treatments are being studied, which are
discussed in this review. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Hormone and Metabolic Research - Category: Endocrinology Authors: Ilanchezhian, Maran Khan, Sophia Okafor, Christian Glod, John Del Rivero, Jaydira Tags: Review Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Hormones | Men | Multiple Endocrine Neoplasia | Multiple Endocrine Neoplasia Syndrome | Neurology | Thyroid | Thyroid Cancer | Thyroidectomy | USA Health